Press Releases for CYTK

Press Releases
Cytokinetics Announces Addition to Board of Directors
Cytokinetics to Present Phase IIa Clinical Trials Data on Omecamtiv Mecarbil at the European Society of Cardiology Congress 2009
Cytokinetics, Incorporated Reports Second Quarter 2009 Financial Results
Cytokinetics to Announce Second Quarter Results on July 29, 2009
Cytokinetics Announces the Initiation of a First-Time-in-Humans, Phase I Clinical Trial of CK-2017357
Cytokinetics to Present at the Eighth Annual Needham Life Sciences Conference
Cytokinetics Presents Clinical Data Relating to Ispinesib in Patients With Metastatic Breast Cancer at the 2009 Annual Meeting of the American Society of Clinical Oncology
Cytokinetics Announces Non-Clinical Data Relating to GSK-923295 Presented at the 2009 Annual Meeting of the American Society of Clinical Oncology
Cytokinetics Announces Presentations of Data From Phase IIa Clinical Trials of CK-1827452 at the 2009 Heart Failure Congress of the European Society of Cardiology
Cytokinetics Presents Clinical Data Relating to SB-743921 in Patients With Non-Hodgkin or Hodgkin Lymphoma at the 2009 Annual Meeting of the American Society of Clinical Oncology
Amgen Exercises Option for Exclusive License to Cytokinetics' Cardiac Contractility Program That Includes CK-1827452
Cytokinetics to Hold a Conference Call Tuesday, May 26, 2009 at 9 AM Eastern Time to Discuss Its Collaboration and Option Agreement With Amgen
Cytokinetics to Present Phase IIa Clinical Trials Data on CK-1827452 at the 2009 Heart Failure Congress of the European Society of Cardiology
Cytokinetics Announces Registered Direct Common Stock Offering of $14.0 Million
Cytokinetics Announces Clinical and Non-Clinical Data Relating to SB-743921, Ispinesib and GSK-923295 to Be Presented at the 2009 Annual Meeting of the American Society of Clinical Oncology
Cytokinetics to Hold Annual Meeting of Stockholders
Cytokinetics to Present at the Eighth Annual JMP Securities Research Conference
Cytokinetics Presents Non-Clinical Data From Its Smooth Muscle Contractility Program at the American Society of Hypertension 24th Annual Scientific Meeting and Exposition
Cytokinetics to Present at the Bank of America and Merrill Lynch Healthcare Conference
Cytokinetics Announces Non-Clinical Data Relating to Its Smooth Muscle Contractility Program to Be Presented at the American Society of Hypertension 24th Annual Scientific Meeting and Exposition
Cytokinetics, Incorporated Reports First Quarter 2009 Financial Results
Cytokinetics to Announce First Quarter Results on April 30, 2009
Cytokinetics Announces Final Phase IIa Clinical Trial Data for CK-1827452 Presented at the 2009 Annual Scientific Sessions of the American College of Cardiology
Cytokinetics Announces Clinical Trials Data Relating to CK-1827452 to be Presented at the 2009 Annual Scientific Sessions of the American College of Cardiology
Cytokinetics Announces Non-Clinical Data Relating to Its Skeletal Muscle Contractility Program Presented at the Biophysical Society 53rd Annual Meeting
Cytokinetics Delivers Clinical Trials Data to Inform Amgen's Option Relating to CK-1827452
Cytokinetics Announces Non-Clinical Data Relating to Its Skeletal Muscle Contractility Program to Be Presented at the Biophysical Society 53rd Annual Meeting
Cytokinetics Announces Addition to Board of Directors - Feb 19 2009 5:40PM
Cytokinetics, Incorporated Reports Fourth Quarter and Year End 2008 Financial Results
Cytokinetics to Announce Fourth Quarter and Year End Results on February 10, 2009
Cytokinetics to Present at BIO CEO and Investor Conference
Cytokinetics Announces Updates Relating to Muscle Biology Research and Non-Clinical Development Programs
Cytokinetics to Present at the 27th Annual JPMorgan Healthcare Conference
Cytokinetics Retains Development and Commercialization Rights to Ispinesib and SB-743921
Cytokinetics Retains Development and Commercialization Rights to Ispinesib and SB-743921
Cytokinetics Announces Phase IIa Clinical Trial Results Relating to CK-1827452 in Patients With Ischemic Cardiomyopathy and Angina
Cytokinetics Announces Clinical and Preclinical Data Regarding Ispinesib Presented at the 31st Annual San Antonio Breast Cancer Symposium
Cytokinetics Announces Clinical Trial Data Regarding SB-743921 Presented at the 2008 Annual Meeting of American Society of Hematology
Cytokinetics Announces Preclinical and Clinical Trial Data Regarding Ispinesib to Be Presented at the 31st Annual San Antonio Breast Cancer Symposium
Cytokinetics to Present at the RBC Capital Markets Healthcare Conference
Cytokinetics Announces Clinical Trial Data Regarding SB-743921 to Be Presented at the 2008 American Society of Hematology Annual Meeting and Exposition
Cytokinetics Files Replacement Shelf Registration Statement
Cytokinetics Announces Data From a Clinical Trial of CK-1827452 in Stable Heart Failure Patients Presented at the 2008 Scientific Sessions of the American Heart Association
Cytokinetics to Present at November Healthcare Conferences
Cytokinetics Announces Clinical Trials Data Relating to CK-1827452 to Be Presented at the 2008 Scientific Sessions of the American Heart Association
Cytokinetics, Incorporated Reports Third Quarter 2008 Financial Results
Cytokinetics to Announce Third Quarter Results on October 30, 2008
Cytokinetics Announces Data Relating to GSK-923295 and SB-743921 Presented at the 2008 EORTC-NCI-AACR International Symposium
Cytokinetics Announces Clinical Trials Data Relating to CK-1827452 Presented at the 12th Annual Scientific Meeting of the Japanese Heart Failure Society
Cytokinetics Announces Data Relating to GSK-923295 and SB-743921 to Be Presented at the 2008 EORTC-NCI-AACR International Symposium
Cytokinetics Announces Clinical Trials Data Relating to CK-1827452 to Be Presented at the 12th Annual Scientific Meeting of the Japanese Heart Failure Society
Cytokinetics to Present at JMP Securities Healthcare Focus Conference
Cytokinetics Announces Clinical Trials Data Relating to CK-1827452 Presented at the 2008 Annual Heart Failure Society of America Conference
Cytokinetics Announces Clinical Trials Data Relating to CK-1827452 to Be Presented at the 2008 Annual Heart Failure Society of America Conference
Cytokinetics Announces Strategic Realignment of Workforce and Operations
Cytokinetics Announces Interim Clinical Trial Data Relating to Ispinesib Presented at the 2008 ASCO Breast Cancer Symposium
Cytokinetics Announces the Initiation of Third Phase IIa Clinical Trial of CK-1827452
Cytokinetics Announces Interim Clinical Trial Data Relating to CK-1827452 Presented at the European Society of Cardiology Congress 2008
Cytokinetics Announces Clinical Trials Data Relating to Ispinesib to Be Presented at the 2008 ASCO Breast Cancer Symposium
Cytokinetics to Present at the NewsMakers in the Biotechnology Industry Conference
Cytokinetics Announces Completion of Interim Safety Analysis in Ongoing Phase IIa Clinical Trial of CK-1827452
Cytokinetics Announces Clinical Trials Data Relating to CK-1827452 to Be Presented at the European Society of Cardiology Congress 2008
Cytokinetics, Incorporated Reports Second Quarter 2008 Financial Results
BeaconEquity.com Issues Technical Trade Alerts on Market Movers: EXXI, IVAN, AXAS, MNKD, CYTK, SIRI
Cytokinetics to Announce Second Quarter Results on July 31, 2008
Cytokinetics Announces Clinical Data Regarding Ispinesib in Combination With Capecitabine
Cytokinetics Announces Third Extension of Research Term Under Collaboration With GlaxoSmithKline
Cytokinetics Announces Late Breaking Trials Presentation Relating to CK-1827452 at the 2008 Heart Failure Congress of the European Society of Cardiology
Cytokinetics Provides Updates From Phase I Clinical Trials of CK-1827452
Cytokinetics to Present Clinical Data on CK-1827452, a Selective Cardiac Myosin Activator, at the 2008 Heart Failure Congress of the European Society of Cardiology
Cytokinetics Announces Clinical Trial Data Related to SB-743921 Presented at the 10th International Conference on Malignant Lymphoma
Cytokinetics to Present at Needham Healthcare Conference
Cytokinetics Announces Clinical Trials Data Presented at the 2008 Annual Meeting of the American Society of Clinical Oncology
Cytokinetics Announces Clinical Trials Data Related to SB-743921 to Be Presented at the 10th International Conference on Malignant Lymphoma
Cytokinetics Announces Addition to Board of Directors - May 27 2008 12:55AM
Cytokinetics Announces Clinical Trials Data to be Presented at the 2008 Annual Meeting of the American Society of Clinical Oncology - May 27 2008 12:55AM
Cytokinetics to Hold Annual Meeting of Stockholders - May 27 2008 12:54AM
Cytokinetics to Present at May Healthcare Conferences - Jun 1 2008 5:15PM
Cytokinetics, Incorporated Reports First Quarter 2008 Financial Results
Cytokinetics Announces the Initiation of Second Phase IIa Clinical Trial of CK-1827452
Cytokinetics to Announce First Quarter Results on April 29, 2008
Cytokinetics Announces Selection of Development Compound That Activates the Skeletal Sarcomere
Cytokinetics Announces Data Relating to GSK-923295 Presented at the 2008 American Association of Cancer Research Annual Meeting
Cytokinetics Announces Non-Clinical and Clinical Data Relating to GSK-923295 to Be Presented at the 2008 American Association of Cancer Research Annual Meeting